178 related articles for article (PubMed ID: 7432882)
1. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.
Wilson CB; Remington JS; Stagno S; Reynolds DW
Pediatrics; 1980 Nov; 66(5):767-74. PubMed ID: 7432882
[TBL] [Abstract][Full Text] [Related]
2. Neurologic and developmental outcome in treated congenital toxoplasmosis.
Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
[TBL] [Abstract][Full Text] [Related]
3. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
[TBL] [Abstract][Full Text] [Related]
4. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
Guerina NG; Hsu HW; Meissner HC; Maguire JH; Lynfield R; Stechenberg B; Abroms I; Pasternack MS; Hoff R; Eaton RB
N Engl J Med; 1994 Jun; 330(26):1858-63. PubMed ID: 7818637
[TBL] [Abstract][Full Text] [Related]
5. Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections.
Stagno S; Reynolds DW; Amos CS; Dahle AJ; McCollister FP; Mohindra I; Ermocilla R; Alford CA
Pediatrics; 1977 May; 59(5):669-78. PubMed ID: 193086
[TBL] [Abstract][Full Text] [Related]
6. Sensorineural hearing loss due to Toxoplasma gondii in children: a case-control study.
Noorbakhsh S; Memari F; Farhadi M; Tabatabaei A
Clin Otolaryngol; 2008 Jun; 33(3):269-73. PubMed ID: 18559038
[TBL] [Abstract][Full Text] [Related]
7. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.
Lackner A; Acham A; Alborno T; Moser M; Engele H; Raggam RB; Halwachs-Baumann G; Kapitan M; Walch C
J Laryngol Otol; 2009 Apr; 123(4):391-6. PubMed ID: 18588736
[TBL] [Abstract][Full Text] [Related]
8. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China.
Zhang XW; Li F; Yu XW; Shi XW; Shi J; Zhang JP
J Clin Virol; 2007 Nov; 40(3):180-5. PubMed ID: 17919973
[TBL] [Abstract][Full Text] [Related]
9. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns.
Lanari M; Lazzarotto T; Venturi V; Papa I; Gabrielli L; Guerra B; Landini MP; Faldella G
Pediatrics; 2006 Jan; 117(1):e76-83. PubMed ID: 16326692
[TBL] [Abstract][Full Text] [Related]
10. [Congenital toxoplasmosis: presentation of a case].
Yuksel D; Van Acker E; De Potter P
Bull Soc Belge Ophtalmol; 1999; 274():21-6. PubMed ID: 10670159
[TBL] [Abstract][Full Text] [Related]
11. Adolescent mothers and their children: changes in maternal characteristics and child developmental and behavioral outcome at school age.
Camp BW
J Dev Behav Pediatr; 1996 Jun; 17(3):162-9. PubMed ID: 8783062
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the postnatal treatment efficacy in congenital toxoplasmosis identified by the newborn screening programme].
Paul M; Jaworska A; Twardosz-Pawlik H; Szczapa J; Stefaniak J
Wiad Parazytol; 2001; 47 Suppl 1():107-12. PubMed ID: 16897960
[TBL] [Abstract][Full Text] [Related]
13. [Follow-up of children after toxoplasmosis infection in pregnancy].
Mayer HO; Stünzner D; Grubbauer HM; Faschinger C; Wochesländer E; Moser M
Zentralbl Gynakol; 1986; 108(24):1482-6. PubMed ID: 3577452
[TBL] [Abstract][Full Text] [Related]
14. Treatment of children with congenital cytomegalovirus infection with ganciclovir.
Michaels MG; Greenberg DP; Sabo DL; Wald ER
Pediatr Infect Dis J; 2003 Jun; 22(6):504-9. PubMed ID: 12799506
[TBL] [Abstract][Full Text] [Related]
15. Congenital toxoplasmosis: long-term follow-up.
Koppe JG; Kloosterman GJ
Padiatr Padol; 1982; 17(2):171-9. PubMed ID: 7099676
[TBL] [Abstract][Full Text] [Related]
16. [Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis].
Paul M
Wiad Parazytol; 1997; 43(1):39-51. PubMed ID: 9289926
[TBL] [Abstract][Full Text] [Related]
17. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of group B streptococcal meningitis.
Wald ER; Bergman I; Taylor HG; Chiponis D; Porter C; Kubek K
Pediatrics; 1986 Feb; 77(2):217-21. PubMed ID: 3511445
[TBL] [Abstract][Full Text] [Related]
19. Outcome to five years of age of children born at 24-26 weeks' gestational age in Victoria. The Victorian Infant Collaborative Study Group.
Doyle LW
Med J Aust; 1995 Jul; 163(1):11-4. PubMed ID: 7541889
[TBL] [Abstract][Full Text] [Related]
20. [Toxoplasma infections in early pregnancy: consequences and management].
Wallon M; Gaucherand P; Al Kurdi M; Peyron F
J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
